A father picks up his young child and give them a kiss.

Financial Story

Investors

Path to grow: Reset. Strengthen. Strive.

Latest News
Jul 16, 2024

Endo, Inc (OTCQX: NDOI) ("Endo"), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling one lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV)...

Jul 15, 2024

Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics' THIOLA EC®. "We're proud to provide high-quality, affordable...

Jul 12, 2024

Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today announced that it has publicly filed a...

View All Press Releases

Our Board

Governance

Endo’s board of directors oversees and advises our leaders to protect the long-term interests of the company and our shareholders. The experienced and independent board members are committed to building sustainable success.

Directors Committees Policies & Guidelines

Overview

This is body copy - it will be turned off in site mgr